News

EnableComp's New CEO Frank Forte to Revolutionize Healthcare RCM

EnableComp's New CEO Frank Forte to Revolutionize Healthcare RCM

EnableComp Appoints Frank Forte as New CEO

EnableComp, a prominent provider of technology-driven solutions aimed at enhancing revenue cycle management in healthcare, has officially announced the appointment of Frank Forte as its new Chief Executive Officer. Forte’s extensive experience and strong track record in executive leadership and healthcare technology are anticipated to propel EnableComp and its innovative E360 RCM™ platform.

Leading Change in Healthcare

Frank Forte takes over the reins from Randy Dobbs, who has successfully led the company for three years and will now transition to the role of Executive Chairman of the Board. Forte brings a wealth of experience, having previously served as CEO at AnatomyIT, a well-known leader in cybersecurity and IT solutions tailored for healthcare sectors.

Forte’s previous roles include Chief Commercial Officer and General Manager at Cloudmed, where he was instrumental in formulating and executing the commercial strategy that ultimately led to significant growth and the company's acquisition by R1. His diverse background across various healthcare services and technology environments, including his tenure at Emerson Electric Corporation, sets a solid foundation for his leadership at EnableComp.

The Vision Ahead

In a recent statement, Ed Sobol, General Partner at Welsh, Carson, Anderson & Stowe, remarked, "We are fortunate to have someone of Frank's caliber as our new CEO to lead the company into its next growth phase." According to Sobol, Forte’s leadership is expected to elevate EnableComp’s already superior technology, extending its offerings to help providers achieve greater and more accurate outcomes within the complex revenue cycle environment.

Enhancing Revenue Cycle Performance

Forte expressed his enthusiasm about stepping into his new role, stating, "I am excited to serve as the EnableComp CEO and continue to build on our track record of innovation and successful client financial outcomes. Our mission is to support providers as they face increasing challenges regarding payer friction, higher denials, and reimbursement complexities.”

About EnableComp

Founded over two decades ago, EnableComp specializes in offering technology-driven solutions that enhance the performance of complex revenue cycles for healthcare organizations. Utilizing its proprietary E360 RCM™ intelligent automation platform, the company has made significant strides in improving financial sustainability for over 1,000 hospitals, health systems, and ambulatory surgery centers throughout the nation.

EnableComp's industry-leading expertise is underscored by its impressive data set of more than 21 million processed claims, which enables the company to optimize revenue recovery and capture across various challenging categories, such as Denials and Complex Claims. In 2024, Black Book recognized EnableComp as the top provider of Specialty Revenue Cycle Management Solutions, further validating its commitment to excellence.

Media Contact Information

For media inquiries, please reach out to Janet Mordecai, Senior Account Director at Amendola Communications for EnableComp. Ensure to connect directly for any specific queries or further information regarding EnableComp's operations and its strategic objectives.

Frequently Asked Questions

What is the significance of Frank Forte's appointment as CEO?

Frank Forte's appointment marks a new chapter for EnableComp, aiming to enhance growth and innovation in healthcare revenue cycle management.

What innovative solutions will EnableComp focus on under Forte's leadership?

Under Forte's leadership, EnableComp will focus on advancing its E360 RCM™ platform and optimizing revenue capture for healthcare providers.

How does EnableComp support healthcare providers?

EnableComp provides comprehensive technology-driven solutions to improve revenue cycle management, assisting providers with complex reimbursement processes.

What experience does Frank Forte bring to EnableComp?

Forte brings extensive leadership experience from AnatomyIT and Cloudmed, highlighting his expertise in healthcare technology and revenue cycle management.

What recent recognition did EnableComp receive?

In 2024, EnableComp was recognized by Black Book as the #1 Specialty Revenue Cycle Management Solution provider.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 154

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 207

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 22

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 225

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 155

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 150

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 233

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
les" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles